Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Rang în acțiuni #31255
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Preț acțiune
$0.39
Capitalizare de piață
$13.79M
Schimbare (1 zi)
-13.53%
Schimbare (1 an)
-68.80%
Țară
IL
Tranzacționează NeuroSense Therapeutics Ltd. (NRSN)

Categorie

Istoricul randamentului dividendelor pentru NeuroSense Therapeutics Ltd. (NRSN)
Randamentul dividendelor (TTM) pentru NeuroSense Therapeutics Ltd. (simbol acțiune: NRSN) la data de 2026 este: 0
Randamentul mediu al dividendelor în ultimii 5 ani: 0.00%
Istoric al randamentului dividendelor pentru NeuroSense Therapeutics Ltd. (NRSN) între 2026 și 2026
Randamentul dividendelor la sfârșitul fiecărui an (TTM)
An Randamentul dividendelor Schimbă
Nu sunt suficiente date pentru perioada selectată.
Randamentele dividendelor (TTM) pentru companii similare sau concurente
Companie Randamentul dividendelor Țara
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.48%
BE